Excellis Health joins forces with KORUS Consulting
April 17, 2019Secure your seat for GTT Russia: 24-26 June
May 29, 2019Join us and Systech online on the 8 May: Global traceability compliance webinar
The Details
Who: Systech
What: Online Live Webinar – “The State of Pharmaceutical Regulatory Compliance: Global Changes and Challenges in Large Trading Regions”
When: 11am (EDT) 8 May 2019
Cost: FREE
All businesses working in the pharmaceutical industry have a duty to protect patients and improve their safety. Serialization and traceability regulations are one way to secure patient safety. It is the responsibility of all in the supply chain to work to eliminate counterfeit trade. We need to do this through compliance to current and future requirements.
Join Systech and members of the Excellis team, including our Senior Director, Christoph Krähenbühl and President-International of Excellis Health Solutions, Karan Narang, for a live webinar on Tuesday 8 May where we will discuss global changes and challenges for implementing against regulations..
Systech is the global technology leader in brand protection, anti-counterfeiting and diversion. Through revolutionizing brand protection, Systech work to keep products authentic across the supply chain and keep businesses compliant to ever changing pharma regulations.
What you will learn
The latest facts and insight on new conditions, timelines, and regulations will be discussed by global regulatory expert, Dirk Rodgers. This webinar will also cover recent additions and changes to global compliance mandates and the impact of these to drug packaging and distribution.
For those who import into Russia, the next traceability challenge is the upcoming serialization deadline in this market. It poses new and complex requirements compared to current regulations in other markets, including the implementation of on-pack cryptographic. These challenges and other global requirements will also be discussed.
Join us
To meet the challenges of global pharma serialization, register now to join us for a live discussion on Tuesday, 8 May.
